Medicine and Dentistry
Branch Retinal Vein Occlusion
51%
Central Retinal Vein Occlusion
51%
Dexamethasone
50%
Intravitreal Implant
50%
Retina Vein Occlusion
46%
Protein
32%
Implant
29%
Bevacizumab
25%
Transthyretin
25%
Caveolin 1
25%
Platelet Derived Growth Factor Receptor
25%
Interleukin 18
25%
Retina
24%
Immunohistochemistry
14%
Therapeutic Procedure
12%
Argon
11%
Upregulation
9%
Serositis
8%
Tandem Mass Tag
8%
Mass Spectrum
8%
Western Blot
7%
Ischemia
6%
Proteomics
6%
Choroid
5%
Vasculotropin
5%
Injection
5%
Peptidylprolyl Isomerase
5%
down Regulation
5%
Vision
5%
Neuroscience
Retinal Vein Occlusion
100%
Dexamethasone
50%
Central Retinal Vein
50%
Protein
33%
Bevacizumab
25%
Transthyretin
25%
Caveolin 1
25%
Interleukin 18
25%
Immunohistochemistry
12%
Proteome
9%
Mass Spectrometry
8%
Ischemia
6%
Peptidylprolyl Isomerase
5%
Pharmacology, Toxicology and Pharmaceutical Science
Branch Retinal Vein Occlusion
50%
Aflibercept
50%
Central Retina Vein Occlusion
50%
Dexamethasone
50%
Proteome
38%
Caveolin 1
25%
Platelet Derived Growth Factor Receptor
25%
Protein
19%
Argon
10%
Multiple Sclerosis
10%
Landrace Pig
7%
Macular Edema
7%
Inflammation
5%
Peptidylprolyl Isomerase
5%
Vasculotropin Receptor 2
5%
Heat Shock Protein
5%
